Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2024-03-01
|
Series: | Pharmaceutical Fronts |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1780496 |
_version_ | 1797260564345389056 |
---|---|
author | Siyu Liu Yanting Pang Zeng Zhao Qingyan Sun |
author_facet | Siyu Liu Yanting Pang Zeng Zhao Qingyan Sun |
author_sort | Siyu Liu |
collection | DOAJ |
first_indexed | 2024-04-24T23:27:20Z |
format | Article |
id | doaj.art-9ed36a6918004cc180c2b24fb9bd2569 |
institution | Directory Open Access Journal |
issn | 2628-5088 2628-5096 |
language | English |
last_indexed | 2024-04-24T23:27:20Z |
publishDate | 2024-03-01 |
publisher | Georg Thieme Verlag KG |
record_format | Article |
series | Pharmaceutical Fronts |
spelling | doaj.art-9ed36a6918004cc180c2b24fb9bd25692024-03-15T23:47:54ZengGeorg Thieme Verlag KGPharmaceutical Fronts2628-50882628-50962024-03-010601e47e6110.1055/s-0044-1780496Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of SepsisSiyu Liu0Yanting Pang1Zeng Zhao2Qingyan Sun3National Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of ChinaNational Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of ChinaNational Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of ChinaNational Key Laboratory of Lead Druggability Research, Shanghai Institute of Pharmaceutical Industry Co. Ltd., China State Institute of Pharmaceutical Industry Co. Ltd., Shanghai, People's Republic of Chinahttp://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1780496Nitidine Chlorideinterleukin-10structural modificationsepsis |
spellingShingle | Siyu Liu Yanting Pang Zeng Zhao Qingyan Sun Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis Pharmaceutical Fronts Nitidine Chloride interleukin-10 structural modification sepsis |
title | Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis |
title_full | Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis |
title_fullStr | Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis |
title_full_unstemmed | Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis |
title_short | Discovery of Topoisomerase I Inhibitor Nitidine Derivatives with IL-10 Enhancing Activity for the Treatment of Sepsis |
title_sort | discovery of topoisomerase i inhibitor nitidine derivatives with il 10 enhancing activity for the treatment of sepsis |
topic | Nitidine Chloride interleukin-10 structural modification sepsis |
url | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1780496 |
work_keys_str_mv | AT siyuliu discoveryoftopoisomeraseiinhibitornitidinederivativeswithil10enhancingactivityforthetreatmentofsepsis AT yantingpang discoveryoftopoisomeraseiinhibitornitidinederivativeswithil10enhancingactivityforthetreatmentofsepsis AT zengzhao discoveryoftopoisomeraseiinhibitornitidinederivativeswithil10enhancingactivityforthetreatmentofsepsis AT qingyansun discoveryoftopoisomeraseiinhibitornitidinederivativeswithil10enhancingactivityforthetreatmentofsepsis |